INDRAMEDCO
INDRAPRASTHA MEDICAL CORPHealthcare
LTP
380.65
CHG · %
+18.8 (+5.20%)
VOL · TODAY
84.74L
PREV CLOSE
361.85
Today's range375 · 405.9
380.65
52-week range342 · 640.85
380.65
Loading candles…
Indraprastha Medical Corporation Ltd. was incorporated in 1988 as a joint venture between Apollo Hospitals Enterprise Ltd. and the Delhi Government. Headquartered in New Delhi, the company operates in the healthcare and hospital industries, focusing on multi-specialty tertiary care hospital services. Its services span over 50 specialties, including cardiology, oncology, organ transplants, and neurosciences. The corporation primarily serves patients in New Delhi, Noida, and the broader North India region. Its notable operations include the flagship Indraprastha Apollo Hospitals located in Sarita Vihar, New Delhi, along with an additional facility in Noida. The company currently manages 52 specialty departments across its facilities.
INDRAMEDCO is not part of any active scan today.
This page is a live market overview for INDRAPRASTHA MEDICAL CORP (INDRAMEDCO) on the NSE. As a listed security, INDRAPRASTHA MEDICAL CORP is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for INDRAMEDCO before placing trades on tick2trade.
As of the latest feed, INDRAMEDCO last traded at ₹380.65 on NSE, up ₹18.8 (5.20%) from the previous close of ₹361.85. Today's session range is ₹375 – ₹405.9, against a 52-week band of ₹342 – ₹640.85. Traded volume today stands at 84.74L shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for INDRAMEDCO in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether INDRAMEDCO is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for INDRAPRASTHA MEDICAL CORP before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in INDRAMEDCO. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated INDRAMEDCO option chain page linked from this overview.
// similar in healthcare314 total